| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 753.648 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 557.569 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 571.433 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 769.069 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 649.78 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 600.421 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 519.206 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 764.114 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 646.978 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 528.725 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 770.168 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 756.562 | 94 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 801.408 | 94 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 589.932 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 744.639 | 94 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 860.898 | 95 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 570.657 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 712.002 | 94 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 816.639 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 732.859 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 740.114 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 784.076 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 661.332 | 93 |